This activity will provide comprehensive and up-to-date information regarding the most recent and relevant laws and clinical practice guidelines regarding the safe and effective management and treatment of pain, including opioid and other substance use disorders. The 8-course series will yield practical guidance for prescribing clinicians who manage patients with pain and/or substance use disorders, including detailed information on appropriate treatment selection and management, risk mitigation strategies, and implementation of diversion and surveillance tools for controlled substances. Completion of this activity in full will satisfy the Drug Enforcement Administration (DEA) 8-hour content training requirement for The Medication Access and Training Expansion (MATE) Act.

Target Audience

This activity is designed for All Drug Enforcement Administration (DEA)-registered practitioners who treat patients with opioid or other substance use disorders, including: physicians, nurse practitioners, physician assistants, and dentists.

Learning Objectives

  • Distinguish appropriate actions for prescribers and dispensers related to the federal laws regarding prescription practices for controlled substances via in person and by way of telemedicine settings.
  • Explain the appropriate use for and application of opioids and non-opioids in clinical practice, including initiation, continuation/discontinuation, forced opioid tapers, and dose escalation.
  • Identify appropriate areas of clinical assessment and evaluation of treatment failure, including how to adequately analyze risks and benefits of specific dosing regimens.
  • Integrate workflows that foster responsible opioid prescribing practices, incorporate appropriate risk mitigation strategies and improve the informed consent process between clinicians and patients.
  • Outline best practices regarding the implementation of tools for diversion and surveillance of controlled substances.

Additional Information

Tarsus Medical Education
Course summary
Available credit: 
  • 8.25 AANP Contact Hours
  • 8.25 AAPA Category I CME
  • 8.25 AMA PRA Category 1 Credit
Course opens: 
Course expires: 

Charles E. Argoff MD

Professor of Neurology

Director of Comprehensive Pain Program

Albany Medical Center

Albany, NY

Timothy J. Atkinson PharmD

National Program Manager, Pain/Opioid Pharmacy Program Specialist

VHA Pain Management, Opioid Safety, PDMP (PMOP)

Director, PGY2 Pain Management & Palliative Care Residency

Murfreesboro, TN

Jeffrey J. Bettinger PharmD

Pain Management Clinical Pharmacist

Saratoga Hospital Medical Group

Schenectady, NY

Jennifer Bolen JD


The J. Bolen Group, LLC

Lenoir City, TN

Michelle E. Brown PharmD, BCPS

Clinical Pharmacy Specialist - Pain and Opioid Stewardship

Eskenazi Health

Indianapolis, IN

Mark P. Garofoli PharmD, MBA, BCGP, CPE, CTTS

Clinical Assistant Professor & Clinical Pain Management Pharmacist

West Virginia University & West Virginia University Medicine

Morgantown, WV

Jessica E. Geiger PharmD, MS, BCPS

Clinical Pharmacy Practitioner

Palliative Care

VA Northern California

Powell, OH

Andrew C. Lodolo PharmD, BCPS, BCCCP, FCCM

Pharmacy Manager, Inpatient Services

Eskenazi Health

Indianapolis, IN

Friedhelm Sandbrink MD

National Executive Director

Pain Management, Opioid Safety, and PDMP

VHA Pain Management, Opioid Safety, PDMP (PMOP)

Murfreesboro, TN

Tanya J. Uritsky PharmD, BCPP

Opioid Stewardship Coordinator

Hospital of the University of Pennsylvania

Malvern, PA


It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.


This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.


To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. If you have questions about this activity, please contact AKH Inc. at [email protected].


In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and PAINWeek. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 8.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.25 AAPA Category 1 CME credits. Approval is valid until Expiration.  Approval is valid until September 29, 2024. PAs should only claim credit commensurate with the extent of their participation.


 This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and PAINWeek. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 8.25 contact hour(s) (which includes 8.25 hour(s) of pharmacology).

Available Credit

  • 8.25 AANP Contact Hours
  • 8.25 AAPA Category I CME
  • 8.25 AMA PRA Category 1 Credit


Please login or register to take this course.

Mocingbird members get an additional 10% discount on all Tarsus Medical Education - Pain Week courses. Use the discount code "MOC10" to claim the additional 10% discount before you check out from your cart.

To take this course you will be redirected to Tarsus Medical Education's website. Simply create a free account with Tarsus Medical Education in order to complete this activity. You can even use your same Mocingbird username and password to create the account.

Mocingbird is pleased to provide our members with discounted access to highly respected and awarded educational partners.